[HTML][HTML] Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1 and XBB. 1 by parental mRNA vaccine or a BA. 5 bivalent booster

C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren… - Nature medicine, 2023 - nature.com
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron sublineages, including the BA. 2-derived BA. 2.75. 2 and the BA. 5-derived BQ. 1.1 …

[引用][C] Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1 and XBB. 1 by parental mRNA vaccine or a BA. 5 bivalent booster

C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren… - Nature Medicine, 2022 - cir.nii.ac.jp
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental
mRNA vaccine or a BA.5 bivalent booster | CiNii Research CiNii 国立情報学研究所 学術情報 …

Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1, and XBB. 1 by 4 doses of parental mRNA vaccine or a BA. 5-bivalent booster

C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren… - bioRxiv, 2022 - biorxiv.org
The newly emerged SARS-CoV-2 Omicron BQ. 1.1, XBB. 1, and other sublineages have
accumulated additional spike mutations that may affect vaccine effectiveness. Here we …

Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1, and XBB. 1 by 4 doses of parental mRNA vaccine or a BA. 5-bivalent booster

C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren… - 2022 - pesquisa.bvsalud.org
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of
parental mRNA vaccine or a BA.5-bivalent booster | PREPRINT-BIORXIV loading 1 2 3 +A A -A …

Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1 and XBB. 1 by parental mRNA vaccine or a BA. 5 bivalent booster

C Kurhade, J Zou, H Xia, M Liu, HC Chang… - Nature …, 2023 - pubmed.ncbi.nlm.nih.gov
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron sublineages, including the BA. 2-derived BA. 2.75. 2 and the BA. 5-derived BQ. 1.1 …

Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1 and XBB. 1 by parental mRNA vaccine or a BA. 5 bivalent booster.

C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren… - 2022 - cabidigitallibrary.org
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron sublineages, including the BA. 2-derived BA. 2.75. 2 and the BA. 5-derived BQ. 1.1 …

[HTML][HTML] Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1, and XBB. 1 by 4 doses of parental mRNA vaccine or a BA. 5-bivalent booster

C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren… - 2022 - europepmc.org
The newly emerged SARS-CoV-2 Omicron BQ. 1.1, XBB. 1, and other sublineages have
accumulated additional spike mutations that may affect vaccine effectiveness. Here we …

[PDF][PDF] Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1, and XBB. 1 by 4 doses of parental mRNA vaccine or a BA. 5-bivalent booster

C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren… - scholar.archive.org
The newly emerged SARS-CoV-2 Omicron BQ. 1.1, XBB. 1, and other sublineages have
accumulated additional spike mutations that may affect vaccine effectiveness. Here we …

Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1 and XBB. 1 by parental mRNA vaccine or a BA. 5 bivalent booster

C Kurhade, J Zou, H Xia, M Liu… - Nature …, 2023 - researchexperts.utmb.edu
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron sublineages, including the BA. 2-derived BA. 2.75. 2 and the BA. 5-derived BQ. 1.1 …

[PDF][PDF] Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1 and XBB. 1 by parental mRNA vaccine or a BA. 5 bivalent booster

C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren… - Nature …, 2023 - scienovate.com
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron sublineages, including the BA. 2-derived BA. 2.75. 2 and the BA. 5-derived BQ. 1.1 …